ScanGrants is a public service listing of grants and other funding types to support health research, programs and scholarship.
2 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
Request for Applications: The Role of Healthcare and Insurance in Improving Outcomes in Cancer Prevention, Early Detection and Treatment
Purpose: To stimulate research that will generate new knowledge of the effects of the US healthcare system structure and the role of insurance on both access to and outcomes of cancer screening, early detection and treatment services. Studies investigating how one or more factors impacting access and outcomes interact – such as insurance status, costs, capacity, personal characteristics, provider characteristics, components of the healthcare delivery system and other known factors – are encouraged.
Please note that:
• Studies may be at the state, multi-state, or national levels, or otherwise involve large populations.
• Studies may be intervention-focused or observational and can use mixed methods.
• If cross-sectional studies are proposed, analysis of both demographic and outcomes data is preferred – such as claims data linked with electronic health records, SEER data, State-level data, National Center for Health Statistics (NCHS) or other existing datasets.
Potential areas of investigation include (but are not limited to):
1. How the structure and capacity of the healthcare system affect appropriate and timely access to cancer screening, early detection, treatment and palliative care services.
2. The provider and system factors that affect treatment patterns and quality of cancer care within the current healthcare systems.
3. The exploration of life course patterns of the entire spectrum of cancer care (from prevention and screening through diagnosis, treatment, survivorship, and supportive/palliative care) by linking diverse data sources for broad patient populations.
Application Deadline: April 1, 2014
1. Not-for-profit institutions located within the United States, its territories and the Commonwealth of Puerto Rico are eligible to apply.
2. United States citizens, non-citizen nationals or permanent residents of the United States are eligible to apply.
3. Independent investigators at all stages of their career are eligible to apply. The usual ACS restriction to investigators within the first six years of their initial independent research appointment does not apply to this RFA.
Mechanism: This Area of Special Interest RFA will use the Research Scholar Grant mechanism.
Length of Study: Awards may not exceed a period of 4 years, although it is anticipated that most applications will require no more than two years to complete the research.
Budget: Awards may not exceed $200,000 per year (direct costs) plus 20% indirect costs.
Peer Review Process: Review of applications at the American Cancer Society is a two-tiered process.
1. Applications will be reviewed by the Cancer Control and Prevention: Health Policy and Health Services Research (CPHPS) Peer Review Committee. Applications recommended for funding by the Peer Review Committee will be forwarded to the Council for Extramural Grants.
2. Council will determine which grants will be funded from all 20 Peer Review Committees after considering the relative merit of applications and available funds.
For questions about this mechanism please contact Joseph Cotter, Program Coordinator of the Cancer Control and Prevention Research program, at firstname.lastname@example.org
Proposal Deadline: April 1
Applications Reviewed in Committee: June
Preliminary Notification of Outcome: September
Applications Reviewed in Council: September
Notifications of Awards: October
Award Start Date: January 1
Damon Runyon Fellowship Award
Application due on or before: March 17, 2014
The Foundation encourages all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention.
Candidates must apply for the fellowship under the guidance of a Sponsor—a scientist (tenured, tenure-track or equivalent position) capable of providing mentorship to the Fellow. In addition to aiding in the planning, execution and supervision of the proposed research, the Sponsor’s role is to foster the development of the Fellow’s overall knowledge, technical and analytical skills, and capacity for scientific inquiry. The Sponsor is also expected to assist the Fellow in attaining his/her career goals.
Awards are made to institutions for the support of the Fellow under direct supervision of the Sponsor. Candidates who have already accepted a postdoctoral research fellowship award are not eligible.
The primary criteria used to evaluate applicants are: •the quality of the research proposal (importance of the problem, originality of approach, appropriateness of techniques and clarity of presentation)
• the qualifications, experience and productivity of both the candidate and the Sponsor
• the quality of the research training environment in which the proposed research is to be conducted and its potential for broadening and strengthening the candidate's ability to independently conduct innovative and substantive research. The proposed research and training environment should represent a new opportunity for the candidate to expand his/her scientific skill set. Direct extensions of the candidate's graduate work (in approach, technique or exact area of study) will not be funded.
Damon Runyon Postdoctoral Research Fellowships are granted for a three-year term with second- and third-year funding contingent upon satisfactory progress reports. Fellows in their first- and third-years of funding will attend Damon Runyon Fellows' Retreats designed to foster collaboration and interaction between scientists working in different fields relevant to cancer.
All fellowship awards are approved by the Board of Directors of the Damon Runyon Cancer Research Foundation acting upon the recommendation of the Fellowship Award Committee (FAC).